Skip to main navigation

BioAtla, Inc logo

preloader
BioAtla, Inc logo
  • Overview
  • News & Events
    • News Releases
    • Events and Presentations
  • Governance
    • Governance Overview
    • Board of Directors
    • Management
    • Committee Composition
  • Financials
    • SEC Filings
    • Quarterly Results
    • Annual Reports
  • Stock
    • Stock Quote & Chart
    • Historic Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • Resources
    • Investor FAQs
    • Email Alerts
    • Contact IR

Quarterly Results

Show all

2023

Q2
  • Earnings Release
  • Form 10-Q
Q1
  • Earnings Release
  • Form 10-Q

2022

Q4
  • Earnings Release
  • Form 10-K
Q3
  • Earnings Release
  • Form 10-Q
Q2
  • Earnings Release
  • 10-Q
Q1
  • Earnings Release
  • 10-Q

2021

Q4
  • Earnings Release
  • 10-K
Q3
  • Earnings Release
  • 10-Q
Q2
  • Earnings Release
  • 10-Q
Q1
  • Earnings Release
  • 10-Q

2020

Q4
  • Earnings Release
  • 10-K
logo-footer

BioAtla® is a leading San Diego-based biopharmaceutical company developing safer and more effective drugs for cancer. Its Conditionally Active Biologics™ (CAB) platform exploits the unique microenvironment of diseased tissue to more effectively target cancer.

BIOATLA®

  • Technology
  • CAB Portfolio
  • Appendix

COMPANY

  • About
  • Team
  • Careers
  • News

LEGAL

  • Privacy Policy
  • Site Map
  • Expanded Access

GET IN TOUCH

  • Contact
  • Corporate Headquarters +1 858-558-0708

FOLLOW US

  • LinkedIn
  • Copyright © 2023 BioAtla®, Inc. All rights reserved